GLI1 and neoplasm: This may to some extent be due to the fact that most preclinical models used for studying the oncogenic effect of HH/GLI signaling did not take into account the cellular and molecular complexity of the tumor microenvironment and the vivid cross-talk between tumor cells, the tumor stroma and the immune system.